Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1069)
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,500
Price
$17.12
Total Value
$42.80K
Shares Held After
18,000
% of Holdings
13.9%
EXELIXIS, INC. (EXEL)
Haley Patrick J. — EVP, Commercial
Shares
32,110
Price
$49.81
Total Value
$1.60M
Shares Held After
357,638
% of Holdings
8.2%
VERACYTE, INC. (VCYT)
EPSTEIN ROBERT S — Director
Shares
10,000
Price
$44.01
Total Value
$440.13K
Shares Held After
52,446
% of Holdings
16.0%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,698
Price
$32.95
Total Value
$55.95K
Shares Held After
242,107
% of Holdings
0.7%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,168
Price
$32.15
Total Value
$37.55K
Shares Held After
243,805
% of Holdings
0.5%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
249
Price
$30.41
Total Value
$7.57K
Shares Held After
244,973
% of Holdings
0.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
48
Price
$111.89
Total Value
$5.37K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
891
Price
$111.30
Total Value
$99.17K
Shares Held After
48
% of Holdings
94.9%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
3,363
Price
$110.35
Total Value
$371.09K
Shares Held After
939
% of Holdings
78.2%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,563
Price
$64.43
Total Value
$100.71K
Shares Held After
490,000
% of Holdings
0.3%
Pharvaris N.V. (PHVS)
Bjork Elisabeth — Director
Shares
10,000
Price
$29.32
Total Value
$293.17K
Shares Held After
15,167
% of Holdings
39.7%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
13,684
Price
$52.75
Total Value
$721.84K
Shares Held After
18,197
% of Holdings
42.9%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
54,933
Price
$1.90
Total Value
$104.37K
Shares Held After
3,364,883
% of Holdings
1.6%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
18,849
Price
$1.80
Total Value
$33.93K
Shares Held After
3,309,950
% of Holdings
0.6%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
2,562
Price
$1.75
Total Value
$4.48K
Shares Held After
3,291,101
% of Holdings
0.1%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,500
Price
$0.92
Total Value
$1.38K
Shares Held After
293,266
% of Holdings
0.5%
Seer, Inc. (SEER)
Horn David R. — PRESIDENT & CFO
Shares
7,303
Price
$1.69
Total Value
$12.35K
Shares Held After
493,959
% of Holdings
1.5%
Entrada Therapeutics, Inc. (TRDA)
Zeiher Bernhardt G — Director
Shares
5,000
Price
$5.86
Total Value
$29.32K
Shares Held After
5,000
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$577.26
Total Value
$115.45K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
245
Price
$574.08
Total Value
$140.65K
Shares Held After
40,713
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
195
Price
$573.00
Total Value
$111.73K
Shares Held After
40,958
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
376
Price
$571.41
Total Value
$214.85K
Shares Held After
41,153
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
552
Price
$570.38
Total Value
$314.85K
Shares Held After
41,529
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
660
Price
$569.30
Total Value
$375.74K
Shares Held After
42,081
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
412
Price
$568.34
Total Value
$234.15K
Shares Held After
42,741
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$566.89
Total Value
$158.73K
Shares Held After
43,153
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
840
Price
$565.95
Total Value
$475.39K
Shares Held After
43,433
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$564.81
Total Value
$722.95K
Shares Held After
44,273
% of Holdings
2.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,949
Price
$563.97
Total Value
$1.10M
Shares Held After
45,553
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,071
Price
$562.94
Total Value
$1.17M
Shares Held After
47,502
% of Holdings
4.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$562.01
Total Value
$247.28K
Shares Held After
49,573
% of Holdings
0.9%
FATE THERAPEUTICS INC (FATE)
TAHL CINDY — Chief Legal and Compliance Officer
Shares
25,590
Price
$1.88
Total Value
$48.08K
Shares Held After
628,155
% of Holdings
3.9%
FATE THERAPEUTICS INC (FATE)
Valamehr Bahram — Director
Shares
28,946
Price
$1.88
Total Value
$54.48K
Shares Held After
635,762
% of Holdings
4.4%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
6,000
Price
$32.00
Total Value
$192.00K
Shares Held After
116,731
% of Holdings
4.9%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$61.30
Total Value
$1.53M
Shares Held After
1,123,095
% of Holdings
2.2%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
85,895
Price
$0.43
Total Value
$36.93K
Shares Held After
955,447
% of Holdings
8.2%
Serina Therapeutics, Inc. (SER)
Marshall Richard Peter — Director
Shares
12,183
Price
$1.65
Total Value
$20.10K
Shares Held After
12,183
% of Holdings
100.0%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
199
Price
$65.51
Total Value
$13.04K
Shares Held After
20,975
% of Holdings
0.9%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
200
Price
$0.95
Total Value
$190.00
Shares Held After
291,766
% of Holdings
0.1%
NEKTAR THERAPEUTICS (NKTR)
ROBIN HOWARD W — Director
Shares
444
Price
$65.51
Total Value
$29.09K
Shares Held After
75,045
% of Holdings
0.6%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200,000
Price
$1.50
Total Value
$299.80K
Shares Held After
800,000
% of Holdings
25.0%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200,000
Price
$1.56
Total Value
$312.08K
Shares Held After
600,000
% of Holdings
33.3%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
68,551
Price
$1.60
Total Value
$109.67K
Shares Held After
400,000
% of Holdings
17.1%
INCYTE CORP (INCY)
Clancy Paul J — Director
Shares
15,000
Price
$94.93
Total Value
$1.42M
Shares Held After
23,741
% of Holdings
38.7%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Wilson Martin — General Counsel
Shares
662
Price
$3.01
Total Value
$2.00K
Shares Held After
677,977
% of Holdings
0.1%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Militello John — Vice President of Finance, Treasurer, Principal Accounting Officer
Shares
384
Price
$3.01
Total Value
$1.16K
Shares Held After
89,780
% of Holdings
0.4%
ROCKET PHARMACEUTICALS, INC. (RCKT)
Shah Gaurav — CEO
Shares
2,409
Price
$3.01
Total Value
$7.26K
Shares Held After
1,040,918
% of Holdings
0.2%
RenovoRx, Inc. (RNXT)
VOLL MARK — Chief Financial Officer
Shares
25,000
Price
$0.79
Total Value
$19.69K
Shares Held After
142,380
% of Holdings
17.6%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
200
Price
$13.80
Total Value
$2.76K
Shares Held After
926,352
% of Holdings
0.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
10,000
Price
$13.98
Total Value
$139.82K
Shares Held After
926,152
% of Holdings
1.1%
Showing 601–650 of 1069 transactions (page 13 of 22)